Company intelligence / Profile preview

Amplitude

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Amplitude Ventures is an active Canadian venture capital firm specializing in precision medicine at the intersection of biology and AI. It supports and scales early- to growth-stage healthcare companies developing innovative therapies and technologies. The firm has over $500 million under management as of 2024 and recently closed a $263 million fund focused on company creation in precision medicine. Its investments have led to successful IPOs such as Repare Therapeutics and Milestone Pharmaceuticals. Portfolio companies are advancing programs across preclinical to late clinical stages.

Therapeutic areas: CardiovascularImmunologyNeurologyOncology
Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateRNA therapy
Industry: Investors

Partnerships

EvotecAltaml

Beyond the preview

Go deeper on Amplitude.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amplitude.

Explore the full profile